No-h-sha forte tablets 0.08 g No. 30

Name: No-h-sha forte tablets 0.08 g No. 30
SKU: an-41671
Price: 252.52 UAH
Availability: InStock

SKU: an-41671

All about product

Description

Specification

Reviews 0

Questions0

new

Hit

In Stock

252.52 грн.

Active ingredient:Drotaverine

Adults:Can

ATC code:A DRUGS AFFECTING THE DIGESTIVE SYSTEM AND METABOLISM; A03 DRUGS USED IN FUNCTIONAL GASTROINTESTINAL DISORDERS; A03A DRUGS USED IN FUNCTIONAL GASTROINTESTINAL DISORDERS; A03A D Papaverine and its derivatives; A03A D02 Drotaverine

Country of manufacture:Ukraine

Diabetics:Can

Delivery

USPS across the USA

Canada Post across Canada

Payment

No-h-sha forte tablets 0.08 g No. 30

252.52 грн.

Description

"No-X-sha ® forte" tablets are used for the following indications:

for therapeutic purposes in: smooth muscle spasms associated with biliary tract diseases: cholecystolithiasis, cholangiolithiasis, cholecystitis, pericholecystitis, cholangitis, papilloma; smooth muscle spasms in urinary tract diseases: nephrolithiasis, urethrolithiasis, pyelitis, cystitis, bladder tenesmus; as an adjunct treatment in: smooth muscle spasms of the gastrointestinal tract: gastric and duodenal ulcers, gastritis, cardio- and/or pylorospasm, enteritis, colitis, spastic colitis with constipation and irritable bowel syndrome accompanied by flatulence; tension headache; gynecological diseases (dysmenorrhea).

Composition

The active substance is drotaverine (one tablet contains drotaverine hydrochloride in terms of dry matter 80 mg).

Excipients: lactose monohydrate, corn starch, magnesium stearate, talc.

Contraindication

hypersensitivity to drotaverine or any component of the drug; severe hepatic, renal or heart failure (small cardiac output syndrome; the drug "No-X-sha ® forte" contains lactose - do not use for the treatment of patients suffering from rare hereditary diseases such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome; breastfeeding period; age up to 12 years.

Method of application

Recommended dosage:

Adults - the usual average dose is 120-240 mg per day in 2-3 doses; for children over 12 years old - the maximum daily dose is 160 mg (divided into ½ tablets 2-4 times a day).

The duration of treatment is determined by the doctor individually depending on the nature and course of the disease.

Application features

Pregnant women

Retrospective clinical and animal studies have shown that oral administration of the drug does not indicate any direct or indirect harmful effects with respect to pregnancy, embryonic development, parturition or postnatal development. However, caution should be exercised when prescribing the drug to pregnant women.

Due to the lack of data, the use of the drug during breastfeeding is not recommended.

There is no information on the effect of the drug on human fertility.

Children

The use of drotaverine in children has not been evaluated in clinical studies. The use of the drug in children under 12 years of age is contraindicated. Use in children over 12 years of age as prescribed by a doctor.

Drivers

If dizziness occurs after using the drug, you should avoid driving a car and performing work that requires increased attention.

Overdose

Symptoms: with a significant overdose of drotaverine, cardiac rhythm and conduction disturbances have been observed, including complete bundle branch block and cardiac arrest, which can be fatal.

In case of overdose, the patient should be under close medical supervision and receive symptomatic treatment, including induction of vomiting and/or gastric lavage.

Side effects

Side effects observed during clinical studies and possibly caused by drotaverine are distributed across organ systems.

On the part of the immune system: allergic reactions, including angioedema, urticaria, rash, itching, redness of the skin, fever, chills, increased body temperature, weakness.

Cardiovascular system: palpitations, arterial hypotension.

From the nervous system: headache, dizziness, insomnia.

Gastrointestinal: nausea, constipation, vomiting.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life - 5 years.

Specifications

Characteristics

Active ingredient

Drotaverine

Adults

Can

ATC code

A DRUGS AFFECTING THE DIGESTIVE SYSTEM AND METABOLISM; A03 DRUGS USED IN FUNCTIONAL GASTROINTESTINAL DISORDERS; A03A DRUGS USED IN FUNCTIONAL GASTROINTESTINAL DISORDERS; A03A D Papaverine and its derivatives; A03A D02 Drotaverine

Country of manufacture

Ukraine

Diabetics

Can

Dosage

80 мг

Drivers

With caution

For allergies

With caution

For children

From the age of 12

Form

Tablets

Method of application

Inside, solid

Nursing

It is impossible.

Pregnant

By doctor's prescription

Primary packaging

blister

Producer

Lekhim-Kharkiv CJSC

Quantity per package

30 pcs

Trade name

No-h-sha

Vacation conditions

Without a prescription

Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions

Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.